What is the first line treatment for impetigo, Streptococcus (Strep) pyogen-9 (Group A beta-hemolytic streptococcus) infection, or Staphylococcus (Staph) skin infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

For impetigo, strep pyogenes, or staph skin infections, the first-line treatment is typically topical mupirocin or retapamulin twice daily for 5 days, as recommended by the Infectious Diseases Society of America 1.

Key Considerations

  • The choice of antibiotic depends on the severity of the infection and the suspected causative organism.
  • For more extensive infections, oral antibiotics such as cephalexin or dicloxacillin may be recommended for 7 days 1.
  • In cases where MRSA is suspected or confirmed, alternative antibiotics such as doxycycline, clindamycin, or sulfamethoxazole-trimethoprim may be used 1.
  • Good wound care, including gentle washing with soap and water, keeping the area clean, and covering with a bandage if draining, is essential alongside antibiotic therapy.

Treatment Options

  • Topical mupirocin or retapamulin for 5 days for mild to moderate infections 1.
  • Oral cephalexin or dicloxacillin for 7 days for more extensive infections 1.
  • Alternative antibiotics such as doxycycline, clindamycin, or sulfamethoxazole-trimethoprim for suspected or confirmed MRSA infections 1.

Important Notes

  • Patients should complete the full course of antibiotics even if symptoms improve quickly to prevent recurrence and antibiotic resistance.
  • The treatment of impetigo, strep pyogenes, or staph skin infections should be guided by the most recent and highest quality evidence, which recommends topical mupirocin or retapamulin as first-line treatment 1.

From the FDA Drug Label

Mupirocin ointment, 2% is indicated for the topical treatment of impetigo due to: Staphylococcus aureus and Streptococcus pyogenes. The first line treatment for impetigo, strep pyogenes infection, or staph skin infection is mupirocin ointment, 2% 2.

  • Key points:
    • Indicated for topical treatment of impetigo due to Staphylococcus aureus and Streptococcus pyogenes
    • Effective in clinical studies with high clinical efficacy rates and pathogen eradication rates 2

From the Research

First Line Treatment for Impetigo, Strep Pyogenes Infection, or Staph Skin Infection

  • The first line treatment for impetigo, strep pyogenes infection, or staph skin infection is topical antibiotics such as mupirocin, retapamulin, and fusidic acid 3, 4.
  • For nonbullous impetigo, topical treatment is usually sufficient, while oral antibiotic therapy may be necessary for bullous impetigo or when topical therapy is impractical 3, 5.
  • Oral antibiotics such as amoxicillin/clavulanate, dicloxacillin, cephalexin, clindamycin, doxycycline, minocycline, trimethoprim/sulfamethoxazole, and macrolides may be used, but penicillin is not effective 3.
  • The choice of antibiotic should take into account the increasing prevalence of antibiotic-resistant bacteria, including methicillin-resistant S. aureus, macrolide-resistant streptococcus, and mupirocin-resistant streptococcus 3, 6.
  • Topical retapamulin has been shown to be effective in the treatment of impetigo and other uncomplicated superficial skin infections caused by S. aureus and S. pyogenes 4.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Impetigo: diagnosis and treatment.

American family physician, 2014

Research

Impetigo.

Advanced emergency nursing journal, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.